Córdoba H, Fernández M, Santos F, Oehling A
Department of Allergology and Clinical Immunology, University Clinic, University of Navarra, Pamplona, Spain.
J Investig Allergol Clin Immunol. 1992 Jul-Aug;2(4):187-90.
As reported in previous studies, ketotifen modifies the number of basophils in peripheral blood, most likely inhibiting their degranulation, which correlates with the lack of exercise-induced respiratory manifestations. In this study, we attempted to measure the approximate amount of intracellular histamine in patients with bronchial asthma sensitized to Dermatophagoides pteronyssinus when they were treated with ketotifen, and compare the values with those of an untreated group and a control group, in order to determine if ketotifen stabilizes the cellular membrane, with the subsequent increase of intracellular mediators. We found that untreated patients had 57% less histamine per basophil than the control group, while treated patients had only 17% less than the controls. This shows that ketotifen acts as a membrane stabilizer, thus inhibiting degranulation and increasing the amount of intracellular mediators.
如先前研究报道,酮替芬可改变外周血中嗜碱性粒细胞的数量,很可能是抑制其脱颗粒,这与缺乏运动诱发的呼吸道表现相关。在本研究中,我们试图测量对粉尘螨致敏的支气管哮喘患者在接受酮替芬治疗时细胞内组胺的大致含量,并将这些值与未治疗组和对照组的值进行比较,以确定酮替芬是否稳定细胞膜,随后增加细胞内介质。我们发现,未治疗的患者每个嗜碱性粒细胞中的组胺比对照组少57%,而接受治疗的患者仅比对照组少17%。这表明酮替芬起到膜稳定剂的作用,从而抑制脱颗粒并增加细胞内介质的量。